IPP Bureau

Flipkart Health+ appoints Prashant Jhaveri as CEO
Flipkart Health+ appoints Prashant Jhaveri as CEO

By IPP Bureau - March 17, 2022

Prashant comes with over 17 years of experience in the health, health insurance and other allied healthcare sectors

Community approach crucial to stamp out diseases
Community approach crucial to stamp out diseases

By IPP Bureau - March 17, 2022

The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges

Roche introduces molecular testing solutions to differentiate Covid-19 variants
Roche introduces molecular testing solutions to differentiate Covid-19 variants

By IPP Bureau - March 17, 2022

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta

BASF to double production capacity of dispersion at its site in Indonesia
BASF to double production capacity of dispersion at its site in Indonesia

By IPP Bureau - March 17, 2022

The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry

USFDA approves Rinvoq for ulcerative colitis
USFDA approves Rinvoq for ulcerative colitis

By IPP Bureau - March 17, 2022

First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology

USFDA EUA for point-of-care Covid-19 rapid PCR test
USFDA EUA for point-of-care Covid-19 rapid PCR test

By IPP Bureau - March 17, 2022

DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes

Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer
Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer

By IPP Bureau - March 17, 2022

First PARP inhibitor to demonstrate overall survival benefit in early breast cancer

Agilent establishes Centre for Excellence at Gujarat Technological University
Agilent establishes Centre for Excellence at Gujarat Technological University

By IPP Bureau - March 17, 2022

The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences

BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa
BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa

By IPP Bureau - March 17, 2022

Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation

Beghou Consulting strengthens advanced analytics and data science team in Pune
Beghou Consulting strengthens advanced analytics and data science team in Pune

By IPP Bureau - March 17, 2022

Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies

Department of Pharmaceuticals release code to regulate medical devices sector
Department of Pharmaceuticals release code to regulate medical devices sector

By IPP Bureau - March 17, 2022

If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code

Biological E gears up for new phase of vaccination drive
Biological E gears up for new phase of vaccination drive

By IPP Bureau - March 17, 2022

To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India

Zen hospital opens dedicated cancer facility
Zen hospital opens dedicated cancer facility

By IPP Bureau - March 16, 2022

According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years

Philips Capsule surveillance receives USFDA clearance
Philips Capsule surveillance receives USFDA clearance

By IPP Bureau - March 16, 2022

Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support

Nipah survivors study to advance new vaccines against highly fatal threat
Nipah survivors study to advance new vaccines against highly fatal threat

By IPP Bureau - March 16, 2022

CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus

Latest Stories

Interviews

Packaging